Home Matinas BioPharma

Matinas BioPharma

In operation
IPO
Targeted Therapy Developer
Basic
Enterprise Profile

Basic Information

Matinas is an emerging clinical-stage biopharmaceutical company headquartered in New Jersey. We are committed to developing novel pharmaceutical products that transform lives. What sets us apart is our targeted therapeutic approach. Our technology and products are strategically designed to overcome the limitations associated with existing therapies. Backed by biopharmaceutical expertise and practical knowledge, we can utilize potent drugs and develop safer, more efficient, and even more clinically effective methods of administration, making a greater impact on improving patients' lives.
Matinas BioPharma Holdings Inc.
NewJersey,United States of America
15~50 people
January 01, 2011
info@matinasbiopharma.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Targeted Technology
Concept
Infectious Diseases Department Infectious Diseases Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs